Buying guide
Apple Watch vs Samsung Galaxy Watch (and Galaxy Ring) in 2026
Comparing 2 humanoid robots across availability, pricing, capabilities, and verified deployments. Current as of 2026.
| Attribute | No image on file | No image on file |
|---|---|---|
| Manufacturer | Apple | Samsung Electronics |
| Form factor | biometric | biometric |
| Maturity | commercial | commercial |
| Availability | shipping-nowshipping | shipping-nowshipping |
| Price | $399-$799 (actual sale price) | $300 (actual sale price) |
| Capability claims |
| — |
| Brain | — | — |
| Verified deployments | 1Apple | 1Samsung Electronics |
| Privacy practices | 13cloud-upload, third-party-sharing, location-tracking, on-device-processing, training-data-use, data-sale, data-retention, biometric-storage, data-deletion-control, data-sale, data-deletion-control, data-retention, biometric-storage | 10cloud-upload, third-party-sharing, data-sale, data-retention, on-device-processing, location-tracking, biometric-storage, data-sale, data-deletion-control, data-retention |
| Sources on file | 26 | 13 |
Editorial summaries
Apple Watch
The Apple Watch (current Series 11 and Ultra 3, September 2025; Series 9/10 and Ultra 2 supported) is a biometric-primary smartwatch and the canonical reference of the biometric cohort, with the broadest FDA-cleared portfolio: ECG and AFib/irregular-rhythm notifications (De Novo 2018), sleep-apnea notifications (2024), and hypertension notifications (2025), plus fall and crash detection and the Vitals app. Its sensors (optical PPG, electrical ECG, temperature, accelerometer/gyro, blood-oxygen) need no subscription for the FDA-cleared medical features. Pricing anchors at about $399 for the Series base (aluminum, GPS), with the Ultra around $799 and the SE around $249 (the SE lacks ECG). A within-entity verified-vs-claimed exemplar: blood-oxygen was disabled in the US in January 2024 over the Masimo ITC ruling and re-enabled in August 2025 via a paired-iPhone calculation redesign. DEPLOY holds the claims to the specific cleared indications: these are cleared features with defined scope, not a general cardiac or sleep diagnostic.
Samsung Galaxy Watch (and Galaxy Ring)
The Samsung Galaxy Watch (the Galaxy Watch 7 anchor at about $300, plus the Watch Ultra and the adjacent Galaxy Ring, all July 2024) is a biometric-primary smartwatch whose BioActive sensor combines optical heart rate, electrical ECG, and bioimpedance. Its FDA-cleared features (held by the Samsung Health Monitor app) include ECG (2021), AFib detection (2023), and sleep-apnea detection (De Novo, February 2024), with no subscription. A within-entity verified-vs-claimed exemplar: Samsung's blood-pressure feature is cleared in Korea and several other markets but NOT in the US, where it remains wellness-grade; DEPLOY surfaces that market-specific clearance variance honestly rather than implying a US clearance. The Galaxy Ring is an adjacent biometric form factor (accelerometer, optical HR, skin temperature for sleep, heart rate, and an Energy Score) with no ECG and no FDA-cleared features.
Machine-readable: this page as markdown.